Skip to main content
NCBI home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1999 Oct;83(10):1125–1130. doi: 10.1136/bjo.83.10.1125

Dry eye after haematopoietic stem cell transplantation

Y Ogawa 1, S Okamoto 1, M Wakui 1, R Watanabe 1, M Yamada 1, M Yoshino 1, M Ono 1, H Yang 1, Y Mashima 1, Y Oguchi 1, Y Ikeda 1, K Tsubota 1
PMCID: PMC1722843  PMID: 10502571

Abstract

AIMS—To determine the incidence, natural course, and severity of dry eye occurring or worsening after haematopoietic stem cell transplantation (SCT).
METHODS—At a tertiary care hospital, 53 patients undergoing allogeneic or autologous SCT followed by at least 180 days of follow up were studied prospectively. Examination included grading of symptoms of dry eye, evaluation of ocular surface, tear break up time, and Schirmer tests with and without nasal stimulation. Meibomian gland secretion was also examined using a slit lamp while applying steady digital pressure.
RESULTS—Of the 53 patients, 44 received allografts. Half of these patients (22) developed dry eye or their pre-existing dry eye worsened after SCT, while none of nine autograft recipients did. Onset of dry eye was 171 (SD 59) days after SCT. Two types of dry eye occurred. One (n=10) was severe with ocular surface findings resembling Sjögren's syndrome and reduction of reflex tearing soon after onset. A mild type (n=12) had unimpaired reflex tearing. Meibomian gland dysfunction (MGD) was more frequent and severe in patients with dry eye and chronic graft versus host disease (GVHD), and overall severity of dry eye was greater in patients with MGD and chronic GVHD.
CONCLUSIONS—Dry eye after SCT occurred only in allograft recipients, and was not evident in autograft recipients. The severe form of dry eye had a tendency to develop rapidly. Further study on the prediction and treatment of severe dry eye after SCT is necessary.



Full Text

The Full Text of this article is available as a PDF (93.2 KB).

Figure 1  .

Figure 1  

Open in a new tab

The serial changes in the ocular surface and tear dynamics evaluation in 10 severe dry eye patients are shown. Good reflex tearing was present before stem cell transplantation (SCT), but this began to decrease at about 3 months after SCT and declined to ⩽10 mm at about 6 months after SCT.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akiyama M., Dale B. A., Sun T. T., Holbrook K. A. Characterization of hair follicle bulge in human fetal skin: the human fetal bulge is a pool of undifferentiated keratinocytes. J Invest Dermatol. 1995 Dec;105(6):844–850. doi: 10.1111/1523-1747.ep12326649. [DOI] [PubMed] [Google Scholar]
  2. Atkinson K. Chronic graft-versus-host disease. Bone Marrow Transplant. 1990 Feb;5(2):69–82. [PubMed] [Google Scholar]
  3. Barletta J. P., Fanous M. M., Margo C. E. Corneal and conjunctival toxicity with low-dose cytosine arabinoside. Am J Ophthalmol. 1992 May 15;113(5):587–588. doi: 10.1016/s0002-9394(14)74736-1. [DOI] [PubMed] [Google Scholar]
  4. Bray L. C., Carey P. J., Proctor S. J., Evans R. G., Hamilton P. J. Ocular complications of bone marrow transplantation. Br J Ophthalmol. 1991 Oct;75(10):611–614. doi: 10.1136/bjo.75.10.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Calissendorff B., el Azazi M., Lönnqvist B. Dry eye syndrome in long-term follow-up of bone marrow transplanted patients. Bone Marrow Transplant. 1989 Nov;4(6):675–678. [PubMed] [Google Scholar]
  6. Ferrara J. L., Deeg H. J. Graft-versus-host disease. N Engl J Med. 1991 Mar 7;324(10):667–674. doi: 10.1056/NEJM199103073241005. [DOI] [PubMed] [Google Scholar]
  7. Franklin R. M., Kenyon K. R., Tutschka P. J., Saral R., Green W. R., Santos G. W. Ocular manifestations of graft-vs-host disease. Ophthalmology. 1983 Jan;90(1):4–13. doi: 10.1016/s0161-6420(83)34604-2. [DOI] [PubMed] [Google Scholar]
  8. Fraunfelder F. T., Meyer S. M. Ocular toxicity of antineoplastic agents. Ophthalmology. 1983 Jan;90(1):1–3. doi: 10.1016/s0161-6420(83)34600-5. [DOI] [PubMed] [Google Scholar]
  9. Hikichi T., Yoshida A., Fukui Y., Hamano T., Ri M., Araki K., Horimoto K., Takamura E., Kitagawa K., Oyama M. Prevalence of dry eye in Japanese eye centers. Graefes Arch Clin Exp Ophthalmol. 1995 Sep;233(9):555–558. doi: 10.1007/BF00404705. [DOI] [PubMed] [Google Scholar]
  10. Hirst L. W., Jabs D. A., Tutschka P. J., Green W. R., Santos G. W. The eye in bone marrow transplantation. I. Clinical study. Arch Ophthalmol. 1983 Apr;101(4):580–584. doi: 10.1001/archopht.1983.01040010580010. [DOI] [PubMed] [Google Scholar]
  11. Jack M. K., Jack G. M., Sale G. E., Shulman H. M., Sullivan K. M. Ocular manifestations of graft-v-host disease. Arch Ophthalmol. 1983 Jul;101(7):1080–1084. doi: 10.1001/archopht.1983.01040020082014. [DOI] [PubMed] [Google Scholar]
  12. Jester J. V., Nicolaides N., Kiss-Palvolgyi I., Smith R. E. Meibomian gland dysfunction. II. The role of keratinization in a rabbit model of MGD. Invest Ophthalmol Vis Sci. 1989 May;30(5):936–945. [PubMed] [Google Scholar]
  13. Lass J. H., Lazarus H. M., Reed M. D., Herzig R. H. Topical corticosteroid therapy for corneal toxicity from systemically administered cytarabine. Am J Ophthalmol. 1982 Nov;94(5):617–621. doi: 10.1016/0002-9394(82)90006-x. [DOI] [PubMed] [Google Scholar]
  14. Lemp M. A. Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes. CLAO J. 1995 Oct;21(4):221–232. [PubMed] [Google Scholar]
  15. Livesey S. J., Holmes J. A., Whittaker J. A. Ocular complications of bone marrow transplantation. Eye (Lond) 1989;3(Pt 3):271–276. doi: 10.1038/eye.1989.37. [DOI] [PubMed] [Google Scholar]
  16. Mencucci R., Rossi Ferrini C., Bosi A., Volpe R., Guidi S., Salvi G. Ophthalmological aspects in allogenic bone marrow transplantation: Sjögren-like syndrome in graft-versus-host disease. Eur J Ophthalmol. 1997 Jan-Mar;7(1):13–18. doi: 10.1177/112067219700700103. [DOI] [PubMed] [Google Scholar]
  17. Nussenblatt R. B., Palestine A. G. Cyclosporine: immunology, pharmacology and therapeutic uses. Surv Ophthalmol. 1986 Nov-Dec;31(3):159–169. doi: 10.1016/0039-6257(86)90035-4. [DOI] [PubMed] [Google Scholar]
  18. Parsons J. T., Fitzgerald C. R., Hood C. I., Ellingwood K. E., Bova F. J., Million R. R. The effects of irradiation on the eye and optic nerve. Int J Radiat Oncol Biol Phys. 1983 May;9(5):609–622. doi: 10.1016/0360-3016(83)90225-0. [DOI] [PubMed] [Google Scholar]
  19. Sale G. E., Beauchamp M. D., Akiyama M. Parafollicular bulges, but not hair bulb keratinocytes, are attacked in graft-versus-host disease of human skin. Bone Marrow Transplant. 1994 Sep;14(3):411–413. [PubMed] [Google Scholar]
  20. Shimazaki J., Goto E., Ono M., Shimmura S., Tsubota K. Meibomian gland dysfunction in patients with Sjögren syndrome. Ophthalmology. 1998 Aug;105(8):1485–1488. doi: 10.1016/S0161-6420(98)98033-2. [DOI] [PubMed] [Google Scholar]
  21. Shimazaki J., Sakata M., Tsubota K. Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol. 1995 Oct;113(10):1266–1270. doi: 10.1001/archopht.1995.01100100054027. [DOI] [PubMed] [Google Scholar]
  22. Shulman H. M., Sullivan K. M., Weiden P. L., McDonald G. B., Striker G. E., Sale G. E., Hackman R., Tsoi M. S., Storb R., Thomas E. D. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980 Aug;69(2):204–217. doi: 10.1016/0002-9343(80)90380-0. [DOI] [PubMed] [Google Scholar]
  23. Tichelli A., Duell T., Weiss M., Socié G., Ljungman P., Cohen A., van Lint M., Gratwohl A., Kolb H. J. Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects. Bone Marrow Transplant. 1996 Jun;17(6):1105–1111. [PubMed] [Google Scholar]
  24. Toda I., Shinozaki N., Tsubota K. Hydroxypropyl methylcellulose for the treatment of severe dry eye associated with Sjögren's syndrome. Cornea. 1996 Mar;15(2):120–128. doi: 10.1097/00003226-199603000-00003. [DOI] [PubMed] [Google Scholar]
  25. Toda I., Tsubota K. Practical double vital staining for ocular surface evaluation. Cornea. 1993 Jul;12(4):366–367. doi: 10.1097/00003226-199307000-00015. [DOI] [PubMed] [Google Scholar]
  26. Tsubota K. The importance of the Schirmer test with nasal stimulation. Am J Ophthalmol. 1991 Jan 15;111(1):106–108. doi: 10.1016/s0002-9394(14)76908-9. [DOI] [PubMed] [Google Scholar]
  27. Tsubota K., Toda I., Yagi Y., Ogawa Y., Ono M., Yoshino K. Three different types of dry eye syndrome. Cornea. 1994 May;13(3):202–209. doi: 10.1097/00003226-199405000-00002. [DOI] [PubMed] [Google Scholar]
  28. Tsubota K., Xu K. P., Fujihara T., Katagiri S., Takeuchi T. Decreased reflex tearing is associated with lymphocytic infiltration in lacrimal glands. J Rheumatol. 1996 Feb;23(2):313–320. [PubMed] [Google Scholar]
  29. Xu K. P., Yagi Y., Toda I., Tsubota K. Tear function index. A new measure of dry eye. Arch Ophthalmol. 1995 Jan;113(1):84–88. doi: 10.1001/archopht.1995.01100010086025. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES